All editions

Edition 10 · Jun 8–Jun 15, 2026 · Signal Log

TARGAN signs to Merck, and a research-grant cycle names Triangle threads

TARGAN, the Raleigh poultry-technology company, signed to sell to Merck Animal Health, a clean outcome for a hardware-heavy agtech business and its Oval Park Capital backing. Alongside it, NCInnovation approved its FY2026-2 grant cycle, funding two university research projects with Triangle ties worth watching for spinouts. Grep-a-Palooza's results also came in: PROTECT3D took the $5,000 pitch prize from the June 4 competition, reported in the June 9 recap.

3

signals

—

capital

0 rounds

0

new companies

discovered

1

Triangle exit

TARGAN signed to Merck Animal Health

Standout of the week

T

TARGAN

Raleigh poultry-technology company

Signed to sell to Merck Animal Health.

TARGAN's WingScan sex-identification and ocular vaccine-delivery biodevice technology moves into Merck Animal Health, which has invested in the company since 2017 and was one of its largest shareholders. The deal is expected to close in Q3 2026, and terms were not disclosed. It is a clean exit for a Raleigh agtech company, and local context for Oval Park Capital and the prior $100M growth financing.

TARGAN·Jun 11

Deep dives

Capital

0 rounds

The week's capital event was TARGAN's exit, covered above.

Recognition

Grep-a-Palooza returned to the Durham Convention Center on June 4 and set an attendance record; the results were reported in GrepBeat's June 9 recap.

PROTECT3D won the Grep-a-Palooza pitch competition, taking the $5,000 prize over Beam Dynamics and BeatPoint. The Duke spinout makes 3D-printed medical bracing and counts the Carolina Hurricanes as a client.

GrepBeat

Infrastructure

A statewide research-grant cycle with two Triangle threads to watch.

Program

NCInnovation funded its FY2026-2 grant cycle, including two Triangle university projects

NCInnovation approved its FY2026-2 applied-research grants, about $7 million across nine university projects. Two carry Triangle ties worth watching for eventual spinouts: NC State's Ricardo Hernandez on controlled-environment strawberry starter plants, and UNC-Chapel Hill's Brianna Vickerman on light-activated cancer drug delivery. These are research projects, not companies yet.

Jun 9NCInnovation
Edition 9Edition 11